This invention concerns the treatment of cartilage disorder and osteoarthritis in particular. More specifically, it relates to the use of FGF-18 in treatment regimens and for the manufacture of a medicament for the treatment of patients having a cartilage disorder such as osteoarthritis, such as for example knee osteoarthritis or secondary hip osteoarthritis. Specifically provided is a preferred treatment scheme comprising once weekly administration of an FGF-18 compound per treatment cycle.
申请公布号
WO2008023063(A2)
申请公布日期
2008.02.28
申请号
WO2007EP58830
申请日期
2007.08.24
申请人
ARES TRADING S.A.;GIMONA, ALBERTO;LADEL, CHRISTOPH H.;VOM BAUR, ELMAR
发明人
GIMONA, ALBERTO;LADEL, CHRISTOPH H.;VOM BAUR, ELMAR